← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

AVTR logoAvantor, Inc.(AVTR)Earnings, Financials & Key Ratios

AVTR•NYSE
$8.43
$5.76B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDiagnostics and life science tools
AboutAvantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.Show more
  • Revenue$6.55B-3.4%
  • EBITDA$164M-89.0%
  • Net Income-$530M-174.5%
  • EPS (Diluted)-0.78-175.0%
  • Gross Margin32.65%-2.8%
  • EBITDA Margin2.5%-88.6%
  • Operating Margin-3.76%-123.5%
  • Net Margin-8.09%-177.2%
  • ROE-9.2%-172.5%
  • ROIC-1.95%-124.4%
  • Debt/Equity0.71+4.1%
  • Interest Coverage-1.60-132.6%
Technical→

AVTR Key Insights

Avantor, Inc. (AVTR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 1.0x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 3.3%
  • ✗Weak momentum: RS Rating 13 (bottom 13%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

AVTR Price & Volume

Avantor, Inc. (AVTR) stock price & volume — 10-year historical chart

Loading chart...

AVTR Growth Metrics

Avantor, Inc. (AVTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.49%
3 Years-4.46%
TTM-1.99%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-177.05%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-176.67%

Return on Capital

10 Years4.81%
5 Years6.43%
3 Years4.54%
Last Year-2.4%

AVTR Recent Earnings

Avantor, Inc. (AVTR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 29, 2026
EPS
$0.17
Est $0.16
+6.3%
Revenue
$1.6B
Est $1.5B
+2.5%
Q1 2026
Feb 11, 2026
EPS
$0.22
Est $0.21
+4.8%
Revenue
$1.7B
Est $1.6B
+1.6%
Q4 2025
Oct 29, 2025
EPS
$0.22
Est $0.22
-2.1%
Revenue
$1.6B
Est $1.6B
-1.3%
Q3 2025
Aug 1, 2025
EPS
$0.24
Est $0.25
-4.0%
Revenue
$1.7B
Est $1.6B
+2.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$0.17vs $0.16+6.3%
$1.6Bvs $1.5B+2.5%
Q1 2026Feb 11, 2026
$0.22vs $0.21+4.8%
$1.7Bvs $1.6B+1.6%
Q4 2025Oct 29, 2025
$0.22vs $0.22-2.1%
$1.6Bvs $1.6B-1.3%
Q3 2025Aug 1, 2025
$0.24vs $0.25-4.0%
$1.7Bvs $1.6B+2.3%
Based on last 12 quarters of dataView full earnings history →

AVTR Peer Comparison

Avantor, Inc. (AVTR) competitors in Diagnostics and life science tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
TMO logoTMOThermo Fisher Scientific Inc.Direct Competitor175.76B472.9526.663.91%15.18%13.23%0.76
DHR logoDHRDanaher CorporationDirect Competitor123.8B174.9234.712.9%14.89%7.06%0.35
MLAB logoMLABMesa Laboratories, Inc.Direct Competitor585.38M105.96-294.3211.47%1.51%2%1.14
SITE logoSITESiteOne Landscape Supply, Inc.Direct Competitor5.42B122.2236.273.62%3.24%9.09%0.58
WAT logoWATWaters CorporationProduct Competitor22.78B349.5332.486.99%11.91%8.04%0.55
A logoAAgilent Technologies, Inc.Product Competitor33.31B117.6925.756.73%18.26%18.67%0.50
TECH logoTECHBio-Techne CorporationProduct Competitor7.42B47.41103.055.23%9.05%5.48%0.23
IDXX logoIDXXIDEXX Laboratories, Inc.Product Competitor46.12B579.2344.2810.42%24.63%70.87%0.67

Compare AVTR vs Peers

Avantor, Inc. (AVTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TMO

Most directly comparable listed peer for AVTR.

Scale Benchmark

vs DHR

Larger-name benchmark to compare AVTR against a more recognizable public peer.

Peer Set

Compare Top 5

vs TMO, DHR, MLAB, SITE

AVTR Income Statement

Avantor, Inc. (AVTR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue1.25B5.86B6.04B6.39B7.39B7.51B6.97B6.78B6.55B6.55B
Revenue Growth %80.44%370.12%3%5.85%15.52%1.71%-7.26%-2.64%-3.41%-1.99%
Cost of Goods Sold814.6M4.04B4.12B4.31B4.88B4.91B4.6B4.5B4.41B4.45B
COGS % of Revenue65.3%68.97%68.2%67.46%66.12%65.35%66.07%66.4%67.35%-
Gross Profit
432.8M▲ 0%
1.82B▲ 320.5%
1.92B▲ 5.5%
2.08B▲ 8.3%
2.5B▲ 20.3%
2.6B▲ 4.0%
2.36B▼ 9.2%
2.28B▼ 3.6%
2.14B▼ 6.1%
2.11B▲ 0%
Gross Margin %34.7%31.03%31.8%32.54%33.88%34.65%33.93%33.6%32.65%32.13%
Gross Profit Growth %35.38%320.47%5.54%8.32%20.29%4%-9.18%-3.57%-6.14%-
Operating Expenses643.2M1.41B1.37B1.37B1.53B1.47B1.67B1.19B2.39B2.38B
OpEx % of Revenue51.56%23.98%22.66%21.49%20.72%19.6%23.93%17.61%36.41%-
Selling, General & Admin643.2M1.41B1.37B1.37B1.53B1.47B1.51B1.64B1.6B1.21B
SG&A % of Revenue51.56%23.98%22.66%21.49%20.72%19.6%21.62%24.19%24.35%-
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses000000160.8M-446.6M790.1M3M
Operating Income
-210.4M▲ 0%
413.5M▲ 296.5%
551.8M▲ 33.4%
706.8M▲ 28.1%
972.2M▲ 37.5%
1.13B▲ 16.3%
696.4M▼ 38.4%
1.08B▲ 55.8%
-246.2M▼ 122.7%
-278.6M▲ 0%
Operating Margin %-16.87%7.05%9.14%11.05%13.16%15.04%10%15.99%-3.76%-4.25%
Operating Income Growth %-2225.25%296.53%33.45%28.09%37.55%16.25%-38.38%55.77%-122.7%-
EBITDA-111.2M818.1M950.7M1.1B1.35B1.54B1.1B1.49B164M136.9M
EBITDA Margin %-8.91%13.95%15.74%17.24%18.3%20.44%15.77%21.97%2.5%2.09%
EBITDA Growth %-258.4%835.7%16.21%15.94%22.61%13.64%-28.46%35.64%-89%-90.82%
D&A (Non-Cash Add-back)99.2M404.6M398.9M395.4M379.2M405.5M402.3M405.5M410.2M415.5M
EBIT-259.3M410M480.6M369.9M970.4M1.12B695.3M1.07B-271.5M-284.4M
Net Interest Income-200.9M-523.8M-440M-307.6M-217.4M-265.8M-284.8M-218.8M-169.8M-172.4M
Interest Income00000000010.5M
Interest Expense200.9M523.8M440M307.6M217.4M265.8M284.8M218.8M169.8M182.9M
Other Income/Expense-249.8M-527.3M-511.2M-644.5M-219.2M-279.1M-285.9M-230.9M-195.1M-192.9M
Pretax Income
-460.2M▲ 0%
-113.8M▲ 75.3%
40.6M▲ 135.7%
62.3M▲ 53.4%
753M▲ 1108.7%
851.1M▲ 13.0%
410.5M▼ 51.8%
853.9M▲ 108.0%
-441.3M▼ 151.7%
-471.5M▲ 0%
Pretax Margin %-36.89%-1.94%0.67%0.97%10.19%11.33%5.89%12.59%-6.74%-7.2%
Income Tax-314.9M-26.9M2.8M-54.3M180.4M164.6M89.4M142.4M88.9M79.9M
Effective Tax Rate %68.43%23.64%6.9%-87.16%23.96%19.34%21.78%16.68%-20.15%-16.95%
Net Income
-112.7M▲ 0%
-86.9M▲ 22.9%
37.8M▲ 143.5%
116.6M▲ 208.5%
572.6M▲ 391.1%
686.5M▲ 19.9%
321.1M▼ 53.2%
711.5M▲ 121.6%
-530.2M▼ 174.5%
-551.4M▲ 0%
Net Margin %-9.03%-1.48%0.63%1.82%7.75%9.14%4.61%10.49%-8.09%-8.42%
Net Income Growth %-165.8%22.89%143.5%208.47%391.08%19.89%-53.23%121.58%-174.52%-177.05%
Net Income (Continuing)-145.3M-86.9M37.8M116.6M572.6M686.5M321.1M711.5M-530.2M-551.4M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-0.84▲ 0%
-0.72▲ 14.3%
-0.84▼ 16.7%
0.09▲ 110.7%
0.85▲ 844.4%
1.01▲ 18.8%
0.47▼ 53.5%
1.04▲ 121.3%
-0.78▼ 175.0%
-0.81▲ 0%
EPS Growth %-873.35%14.29%-16.67%110.71%844.44%18.82%-53.47%121.28%-175%-176.67%
EPS (Basic)-0.84-0.72-0.840.090.861.020.481.05-0.78-
Diluted Shares Outstanding496.5M496.5M401.2M583.4M599.6M679.4M678.4M681.9M679.3M679.3M
Basic Shares Outstanding496.5M496.5M401.2M576.3M590.5M650.9M675.6M680.3M678M678M
Dividend Payout Ratio--82.8%-------

AVTR Balance Sheet

Avantor, Inc. (AVTR) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets1.83B1.9B2.02B2.23B2.48B2.66B2.38B2.15B2.45B2.4B
Cash & Short-Term Investments185.4M184.7M186.7M286.6M301.7M372.9M262.9M261.9M365.4M279.3M
Cash Only185.4M184.7M186.7M286.6M301.7M372.9M262.9M261.9M365.4M279.3M
Short-Term Investments0000000000
Accounts Receivable875M931.2M988.8M1.11B1.22B1.22B1.15B1.03B1.07B1.1B
Days Sales Outstanding256.0357.9659.7563.5660.3959.260.2655.6659.8661.37
Inventory695.1M671.1M711.2M739.6M872M913.5M828.1M731.5M818.2M810.3M
Days Inventory Outstanding311.4660.5663.0162.5965.1867.9165.6659.2867.6865.74
Other Current Assets78.3M112.6M134.8M91.4M81.4M153.1M143.7M118.7M193M209.9M
Total Non-Current Assets8.61B8.01B7.75B7.68B11.42B10.81B10.59B9.97B9.34B9.26B
Property, Plant & Equipment663.5M598.6M557M549.9M705.5M727M737.5M708.1M766.8M766.2M
Fixed Asset Turnover1.88x9.80x10.84x11.63x10.47x10.33x9.45x9.58x8.54x8.58x
Goodwill2.85B2.78B2.77B2.86B5.34B5.65B5.72B5.54B4.99B4.95B
Intangible Assets4.99B4.57B4.22B4.05B5.14B4.13B3.78B3.36B3.19B3.1B
Long-Term Investments0000000000
Other Non-Current Assets112.6M63M205.2M216.7M233.1M293.5M358.3M360.4M396M1.63B
Total Assets
10.45B▲ 0%
9.91B▼ 5.1%
9.77B▼ 1.4%
9.91B▲ 1.4%
13.9B▲ 40.3%
13.46B▼ 3.1%
12.97B▼ 3.7%
12.11B▼ 6.6%
11.79B▼ 2.6%
11.66B▲ 0%
Asset Turnover0.12x0.59x0.62x0.65x0.53x0.56x0.54x0.56x0.56x0.55x
Asset Growth %819.75%-5.12%-1.4%1.36%40.28%-3.12%-3.65%-6.62%-2.64%-16.44%
Total Current Liabilities1.1B1.1B1.07B1.24B1.45B1.66B1.48B2.01B1.38B1.37B
Accounts Payable542M557.4M560.2M678.9M755.1M758.2M625.9M662.8M741.7M735.5M
Days Payables Outstanding242.8650.349.6357.4556.4456.3749.6353.7161.3559.05
Short-Term Debt109M142.4M93.5M26.4M45.2M364.2M259.9M821.1M30.8M37M
Deferred Revenue (Current)0000000000
Other Current Liabilities374.3M319.8M346.6M492.9M600.7M486.5M544.3M475M559.1M594.8M
Current Ratio1.66x1.73x1.88x1.80x1.71x1.60x1.61x1.07x1.78x1.78x
Quick Ratio1.03x1.12x1.22x1.20x1.11x1.05x1.05x0.70x1.18x1.18x
Cash Conversion Cycle324.6368.2273.1368.6969.1370.7476.2961.2366.1968.06
Total Non-Current Liabilities11.96B11.87B6.24B5.99B8.25B6.95B6.24B4.15B4.85B4.71B
Long-Term Debt7.01B6.78B5.02B4.87B6.98B5.92B5.28B3.23B3.92B0
Capital Lease Obligations0000000000
Deferred Tax Liabilities1.05B907.5M785.4M723.9M913M731.4M612.8M557.3M557.1M2.19B
Other Non-Current Liabilities3.9B4.18B428.2M398.1M358.4M295.4M350.3M358.3M378.2M5.33B
Total Liabilities13.07B12.96B7.31B7.23B9.7B8.61B7.72B6.16B6.23B6.07B
Total Debt7.12B6.92B5.12B4.89B7.02B6.29B5.54B4.06B3.95B37M
Net Debt6.93B6.74B4.93B4.61B6.72B5.91B5.27B3.79B3.58B-242.3M
Debt / Equity--2.08x1.83x1.67x1.29x1.05x0.68x0.71x0.71x
Debt / EBITDA-8.46x5.38x4.44x5.20x4.09x5.04x2.72x24.06x0.27x
Net Debt / EBITDA-8.24x5.19x4.18x4.97x3.85x4.80x2.55x21.83x21.83x
Interest Coverage-1.29x0.78x1.09x1.20x4.46x4.20x2.44x4.90x-1.60x-1.55x
Total Equity
-2.62B▲ 0%
-3.05B▼ 16.5%
2.46B▲ 180.7%
2.67B▲ 8.6%
4.2B▲ 56.9%
4.86B▲ 15.7%
5.25B▲ 8.2%
5.96B▲ 13.4%
5.57B▼ 6.6%
5.59B▲ 0%
Equity Growth %-413.16%-16.47%180.68%8.61%56.94%15.69%8.18%13.4%-6.58%1.03%
Book Value per Share-5.28-6.156.144.587.007.157.748.748.198.23
Total Shareholders' Equity-2.62B-3.05B2.46B2.67B4.2B4.86B5.25B5.96B5.57B5.59B
Common Stock001.75B1.74B2.75B3.79B3.83B3.94B3.98B3.99B
Retained Earnings-156.3M-238.4M-203.7M-88.7M483.9M1.17B1.49B2.2B1.67B0
Treasury Stock00000000-75.7M0
Accumulated OCI26.4M-66.5M-85.9M21.7M-43.2M-100.3M-69M-184M-16.9M-43.7M
Minority Interest0000000000

AVTR Cash Flow Statement

Avantor, Inc. (AVTR) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-167.5M200.5M354M929.8M953.6M843.6M870M840.8M623.8M623.8M
Operating CF Margin %-13.43%3.42%5.86%14.54%12.91%11.23%12.49%12.39%9.52%-
Operating CF Growth %-329.77%219.7%76.56%162.66%2.56%-11.54%3.13%-3.36%-25.81%-118.53%
Net Income-145.3M-86.9M37.8M116.6M572.6M686.5M321.1M711.5M-530.2M-551.4M
Depreciation & Amortization99.2M404.6M398.9M395.4M379.2M405.5M402.3M405.5M410.2M415.5M
Stock-Based Compensation48.2M18.4M67.9M44.1M50.7M45.8M40.5M46.8M46.4M42.6M
Deferred Taxes-323.6M-139.7M-106.7M-87.5M-17.7M-69.1M-172.4M-46.9M7.7M9.9M
Other Non-Cash Items81.4M97.9M142.7M441.7M83.3M96.2M261.9M-323.8M888.6M865.3M
Working Capital Changes72.6M-93.8M-186.6M19.5M-114.5M-321.3M16.6M47.7M-198.9M-208.7M
Change in Receivables14.1M-83.4M-68.9M-102.4M-111.8M-45.2M77M45.9M13.6M16M
Change in Inventory19.7M-41.1M-71.1M-69.7M-129.8M-112.5M30.3M-18.5M-109.4M-104M
Change in Payables31.8M29.4M5.1M110.6M64.9M15.6M-139.6M59.6M42.4M39.6M
Cash from Investing-6.68B-23.2M-42.1M-59.1M-4.12B-109.6M-143.7M438.9M-130.5M-134.3M
Capital Expenditures-25.2M-37.7M-51.6M-61.6M-111.1M-133.4M-146.4M-148.8M-128.8M-134.3M
CapEx % of Revenue2.02%0.64%0.85%0.96%1.5%1.78%2.1%2.19%1.97%-
Acquisitions-6.66B000-4.01B-20.2M0000
Investments----------
Other Investing9.9M14.5M9.5M2.5M3.5M1.5M2.7M587.7M-1.7M0
Cash from Financing6.96B-170.3M-307.8M-782.9M3.22B-648.7M-843.7M-1.28B-409.4M-483M
Debt Issued (Net)5.96B-149.8M-1.88B-738.5M2.3B-620.4M-846M-1.34B-318.7M-392.8M
Equity Issued (Net)3.05B01.6B0941.2M-13.2M-13.7M-8.6M-75.6M-71.4M
Dividends Paid-1.7B0-31.3M-64.6M-64.6M-32.4M0000
Share Repurchases00-2.63B-20.2M-25.8M-13.2M-13.7M-8.6M-80.7M-79.4M
Other Financing-341M-20.5M-3.9M20.2M41.9M17.3M16M69.2M-15.1M-18.8M
Net Change in Cash
122.5M▲ 0%
-800K▼ 100.7%
1.6M▲ 300.0%
99.9M▲ 6143.8%
37.9M▼ 62.1%
69.8M▲ 84.2%
-109.2M▼ 256.4%
-23M▲ 78.9%
103.6M▲ 550.4%
-36.7M▲ 0%
Free Cash Flow
-192.7M▲ 0%
162.8M▲ 184.5%
302.4M▲ 85.7%
868.2M▲ 187.1%
842.5M▼ 3.0%
710.2M▼ 15.7%
723.6M▲ 1.9%
692M▼ 4.4%
495M▼ 28.5%
438.9M▲ 0%
FCF Margin %-15.45%2.78%5.01%13.58%11.41%9.45%10.39%10.2%7.55%6.7%
FCF Growth %-548.14%184.48%85.75%187.1%-2.96%-15.7%1.89%-4.37%-28.47%-34.14%
FCF per Share-0.390.330.751.491.411.051.071.010.730.73
FCF Conversion (FCF/Net Income)1.49x-2.31x9.37x7.97x1.67x1.23x2.71x1.18x-1.18x-0.80x
Interest Paid137.2M481.3M405.5M317.8M187M242.2M267M4.2M1.6M57.1M
Taxes Paid31.5M65.6M112.3M42.7M144.7M256.9M224.4M247.8M145M87.5M

AVTR Key Ratios

Avantor, Inc. (AVTR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)--1.54%4.54%16.67%15.17%6.35%12.69%-9.2%-9.59%
Return on Invested Capital (ROIC)-6.27%7.75%7.47%7.23%8.01%7.82%4.91%8.02%-1.95%-1.95%
Gross Margin34.7%31.03%31.8%32.54%33.88%34.65%33.93%33.6%32.65%32.13%
Net Margin-9.03%-1.48%0.63%1.82%7.75%9.14%4.61%10.49%-8.09%-8.42%
Debt / Equity--2.08x1.83x1.67x1.29x1.05x0.68x0.71x0.71x
Interest Coverage-1.29x0.78x1.09x1.20x4.46x4.20x2.44x4.90x-1.60x-1.55x
FCF Conversion1.49x-2.31x9.37x7.97x1.67x1.23x2.71x1.18x-1.18x-0.80x
Revenue Growth80.44%370.12%3%5.85%15.52%1.71%-7.26%-2.64%-3.41%-1.99%

AVTR SEC Filings & Documents

Avantor, Inc. (AVTR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Apr 23, 2026·SEC

Material company update

Apr 1, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 7, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Aug 1, 2025·SEC

AVTR Frequently Asked Questions

Avantor, Inc. (AVTR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Avantor, Inc. (AVTR) reported $6.55B in revenue for fiscal year 2025. This represents a 848% increase from $691.3M in 2016.

Avantor, Inc. (AVTR) saw revenue decline by 3.4% over the past year.

Avantor, Inc. (AVTR) reported a net loss of $551.4M for fiscal year 2025.

Dividend & Returns

Avantor, Inc. (AVTR) has a return on equity (ROE) of -9.2%. Negative ROE indicates the company is unprofitable.

Avantor, Inc. (AVTR) generated $438.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More AVTR

Avantor, Inc. (AVTR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.